Evidence map›Paper›PMID 41083899›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2025

Transcriptome profiling of human dermal MDPL fibroblasts reveals a characteristic molecular signature providing insights into pathogenic mechanisms.

Michela Murdocca, Gerardo Pepe, Serena Maccaroni, Paola Spitalieri, Manuela Helmer-Citterich, Giuseppe Novelli, Federica Sangiuolo

Abstract read
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michela MurdoccaDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133, Rome, Italy.
Gerardo PepeDepartment of Biology, University of Rome "Tor Vergata", Via Della Ricerca Scientifica 1, 00133, Rome, Italy.
Serena MaccaroniDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133, Rome, Italy.
Paola SpitalieriDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133, Rome, Italy.
Manuela Helmer-CitterichDepartment of Biology, University of Rome "Tor Vergata", Via Della Ricerca Scientifica 1, 00133, Rome, Italy.
Giuseppe NovelliDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133, Rome, Italy.
Federica SangiuoloDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133, Rome, Italy. sangiuolo@med.uniroma2.it.ORCID 0000-0002-6227-4248

Funding

European Union-NextGeneration EU Drugs based on RNA TechnologyEuropean Union-NextGeneration EU M4-C2-I1.4European Union-NextGeneration EU National Center for Gene TherapyEuropean Union-NextGeneration EU PNRR Next generation EUEuropean Union-NextGeneration EU Spoke 5 (CUP E83C22003200001)European Union-NextGenerationEU CN3-Spoke 7 (code: CN00000041; PNRR-Mission 4European Union-NextGenerationEU Component 2; Investment 1.4)European Union-NextGenerationEU Drugs based on RNA TechnologyEuropean Union-NextGenerationEU National Center for Gene TherapyMinistero dell' Università e della Ricerca Scientifica, PRIN Prot. 20223WFJJ3
6 · The paper itself

Abstract

The emerging perception that the mammalian dermis encloses fibroblasts with differing functional identities has profound implications for understanding a wide range of genetic pathological states, including aging. MDPL syndrome (mandibular hypoplasia, deafness, progeroid characteristics, and lipodystrophy; MIM #615381) is an extremely rare, genetic progeroid disorder. Patients reported variants in the POLD1 gene (NM_002691.3), encoding for the evolutionarily conserved catalytic subunit of DNA polymerase delta (Polδ). The protein is a critical enzyme reliable for synthesizing nascent DNA strands in the eukaryotic genome. Importantly, Polδ also serves to repair DNA lesions due to mutagen exposure. As the natural history of MDPL still remains poorly known, we have performed RNA sequencing analyses on human dermal fibroblasts (HDFs) of two MDPL patients, heterozygotes for p.Ser605del, compared to WT HDFs. The bioinformatic analyses identify differentially expressed transcripts related to the extracellular matrix of connective tissue and transduction signal markers. Successively, we shed light on the capacity of MDPL cells to respond to and repair DNA damage by comparing transcript levels between X-irradiated MDPL HDFs and non-irradiated ones. Importantly, the results allowed us to identify specific downregulated molecular traits in irradiated MDPL HDFs, including those genes closely involved in the mechanisms of DNA replication and repair. These data were further validated at the functional level, choosing four pivotal proteins (CDC6 (Cell Division Cycle 6), CLSPN (Claspin), XRCC3 (X-Ray Repair Cross Complementing 3), RAD51 (DNA repair protein RAD51 homolog 1)) involved in interconnected pathways ensuring genomic stability. This work provides critical insights into the pathogenesis and the regulatory mechanisms of MDPL syndrome and related diseases, paving the way for future therapeutic interventions. KEY MESSAGES: We identified a molecular signature in MDPL human dermal fibroblasts by transcriptomic profiling. We identified specific markers linked to the extracellular matrix of connective tissue and transduction signal markers. We ascertained in irradiated MDPL human dermal fibroblasts specific downregulated molecular traits, involved in the mechanisms of DNA replication and repair. We validated at functional and biochemical level specific those proteins involved in pathways ensuring genomic stability. The markers identified could be targeted for therapeutic intervention in MDPL syndrome and aging-related diseases.

Indexed as

DermisFibroblastsGene Expression ProfilingLipodystrophyProgeriaTranscriptomeDNA DamageDNA Polymerase IIIDNA RepairHumansSkinDNA Polymerase IIIAgingDNA repairMDPL syndromePOLD1RNA sequencing

Identifiers

PMID41083899
PMCPMC12675696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.